Akèy › Maladi poumon entèstisyèl › South Carolina › Charleston
Etid klinik pou Maladi poumon entèstisyèl nan Charleston, SC
13 etid pou Maladi poumon entèstisyèl ap chèche patisipan nan sit nan ak bò kote Charleston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Ap rekriteFaz 3
- Lowcountry Lung and Critical Care, Charleston
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Ap rekriteFaz 3
- Medical University of South Carolina, Charleston
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Ap rekriteFaz 2
- MUSC, Charleston
SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers
Ap rekrite
- Medical University of South Carolina, Charleston
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Ap rekriteFaz 2
- Medical University of South Carolina, Charleston
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Ap rekriteFaz 2
- Clinical Research Site, Charleston
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Ap rekrite
- Medical University of South Carolina, Charleston
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Ap rekriteEtid obsèvasyon
- Medical University of South Carolina, Charleston
Platform Clinical Study for Conquering Scleroderma
Ap rekriteFaz 2
- Medical University of South Carolina (MUSC), Charleston
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
Ap rekriteEtid obsèvasyon
- Medical University of South Carolina, Charleston
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Ap rekriteFaz 3
- Medical University of South Carolina-Nexus, Charleston
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
Ap rekriteEtid obsèvasyon
- Medical University of South Carolina, Charleston
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Ap rekriteFaz 2
- aTyr Investigative Site, Charleston
Etid Maladi poumon entèstisyèl nan lòt vil
- New York City, NY18 etid
- Philadelphia, PA16 etid
- Los Angeles, CA14 etid
- Kansas City, KS13 etid
- Durham, NC13 etid
- Chicago, IL12 etid
- Houston, TX12 etid
- Aurora, CO11 etid
- Ann Arbor, MI11 etid
- Salt Lake City, UT9 etid
- Dallas, TX9 etid
- Boston, MA9 etid
Lòt etid nan Charleston
- Depresyon19 etid
- Akidan serebavaskilè18 etid
- Ensifizyans kadyak18 etid
- Kansè Poumon ki pa ti selil16 etid
- Twoub Estres Post-Traumatik16 etid
- Maladi kadyovaskilè15 etid
- Kansè pwostat15 etid
- Kansè (tout kalite)14 etid
- Karsinòm selil skuamèz tèt ak kou14 etid
- Maladi Parkinson13 etid
- Kansè nan tete12 etid
- Kansè poumon11 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.